These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32979020)

  • 21. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis.
    Yoo JJ; Kim SG; Kim YS; Lee B; Jeong SW; Jang JY; Lee SH; Kim HS; Jun BG; Kim YD; Cheon GJ
    Medicine (Baltimore); 2020 Jan; 99(5):e18913. PubMed ID: 32000397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.
    Kim BH; Chung JW; Lee CS; Jang ES; Jeong SH; Kim N; Kim JW
    Korean J Intern Med; 2019 Nov; 34(6):1233-1243. PubMed ID: 30759966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis.
    Zaghloul SG; Wahab EA; Seleem WM; Hanafy AS; Gomaa AF; Lakouz K; Amin AI
    Drug Discov Ther; 2019; 13(2):108-113. PubMed ID: 31080201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
    Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
    J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation.
    Leithead JA; Rajoriya N; Tehami N; Hodson J; Gunson BK; Tripathi D; Ferguson JW
    Gut; 2015 Jul; 64(7):1111-9. PubMed ID: 25281417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.
    Kim SG; Larson JJ; Lee JS; Therneau TM; Kim WR
    Liver Transpl; 2017 Jun; 23(6):733-740. PubMed ID: 28187503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis.
    Jeong HW; Kim JH; Han SB; Kwon HM; Jun IG; Song JG; Hwang GS
    Ann Hepatol; 2024; 29(4):101474. PubMed ID: 38331385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials.
    Thiele M; Albillos A; Abazi R; Wiest R; Gluud LL; Krag A
    Liver Int; 2015 Aug; 35(8):2009-16. PubMed ID: 25581713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial.
    Hung HH; Chang CJ; Hou MC; Liao WC; Chan CC; Huang HC; Lin HC; Lee FY; Lee SD
    J Hepatol; 2012 May; 56(5):1025-1032. PubMed ID: 22266602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
    Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
    J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis.
    Fallahzadeh MA; Asrani SK; Tapper EB; Saracino G; Rahimi RS
    World J Clin Cases; 2022 Aug; 10(23):8097-8106. PubMed ID: 36159543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blockers in liver cirrhosis.
    Giannelli V; Lattanzi B; Thalheimer U; Merli M
    Ann Gastroenterol; 2014; 27(1):20-26. PubMed ID: 24714633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study.
    Jensen MD; Watson H; Vilstrup H; Jepsen P
    Clin Epidemiol; 2023; 15():775-783. PubMed ID: 37366419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
    Sinha R; Lockman KA; Mallawaarachchi N; Robertson M; Plevris JN; Hayes PC
    J Hepatol; 2017 Jul; 67(1):40-46. PubMed ID: 28213164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.
    Trebicka J; von Heydebrand M; Lehmann J; Tofteng F; Busk T; Jensen HL; Rohde J; Reiberger T; Mortensen C; Schierwagen R; Klein S; Møller S; Bendtsen F; Krag A
    J Hepatol; 2016 Jun; 64(6):1265-73. PubMed ID: 26827791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis.
    Kumar A; Sharma P; Anikhindi SA; Prajapati R; Agarwal R; Sharma B; Bansal N; Singla V; Arora A
    J Clin Exp Hepatol; 2017 Dec; 7(4):275-283. PubMed ID: 29234190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis.
    Xu X; Gao F; Wang T; Yang Z; Zhao Q; Qi X
    Ann Med; 2024 Dec; 56(1):2305935. PubMed ID: 38271554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.